- ICH GCP
- EU 임상 시험 레지스트리
최신 시험
EudraCT Number: 2004-004148-34 | Sponsor Protocol Number: B9E-XM-O435 | Start Date: 2005-02-25 | ||||||
Sponsor Name: Dr. José Ignacio Chacón López-Muñiz | ||||||||
Full Title: ENSAYO EN FASE I/II DE LA COMBINACIÓN DE GEMCITABINA EN INFUSIÓN PROLONGADA Y PACLITAXEL ADMINISTRADOS DE FORMA QUINCENAL EN EL TRATAMIENTO DE PRIMERA LÍNEA DE PACIENTES CON CÁNCER DE MAMA AVANZADO | ||||||||
Medical condition: Cancer de mama avanzado | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||
Trial protocol: ES (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001060-50 | Sponsor Protocol Number: CSPP100A2303 | Start Date: 2005-02-25 | ||||||
Sponsor Name: Novartis Pharma Services AG | ||||||||
Full Title: An eight-week, randomized, double-blind, multi-center, active-controlled, parallel group study to evaluate the safety and efficacy of an aliskiren based regimen compared to a lisinopril based regim... | ||||||||
Medical condition: Hypertension | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: HU (Completed) ES (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2005-000693-45 | Sponsor Protocol Number: RCOMP05 | Start Date: 2005-02-24 | |||||||||||
Sponsor Name: G.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI | |||||||||||||
Full Title: A phase II study for the treatment of patients with splenic marginal lymphoma with the combination of Cyclophosfamide, Vincristine, Liposomal Doxorubicin, Predinisone and Rituximab | |||||||||||||
Medical condition: Treatment of patients with newly diagnosed splenic marginal non Hodgkin lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-005101-29 | Sponsor Protocol Number: KCH-MDS-04-1.0 | Start Date: 2005-02-24 | |||||||||||
Sponsor Name: King's College Hospital NHS Foundation Trust [...] 1. King's College Hospital NHS Foundation Trust 2. King's College London | |||||||||||||
Full Title: THE EFFICACY AND SAFETY OF LENALIDOMIDE (Revlimid®) MONOTHERAPY IN RED BLOOD CELL TRANSFUSION DEPENDENT SUBJECTS WITH MYELODYSPLASTIC SYNDROME ASSOCIATED WITH A DEL (5q) CYTOGENETIC ABNORMALITY | |||||||||||||
Medical condition: Myelodysplastic Syndrome (MDS) associated with a Del (5q) cytogenetic abnormality | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-003866-13 | Sponsor Protocol Number: CCR102881 | Start Date: 2005-02-24 | ||||||
Sponsor Name: GlaxoSmithKline Research & Development Limited | ||||||||
Full Title: A phase IIb, 96 week, randomised, partially,double-blinded,multicentre,parallel group, repeat dose study to evaluate the safety, tolerability, pharmacokinetics and antiviral effect of GW873140 in c... | ||||||||
Medical condition: Treatment of HIV-1 infections | ||||||||
|
||||||||
Population Age: Adolescents, Adults | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) IT (Prematurely Ended) GB (Prematurely Ended) BE (Completed) ES (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-004160-67 | Sponsor Protocol Number: Protocol F1J-MC-SBCT (a) | Start Date: 2005-02-24 | ||||||
Sponsor Name: Eli Lilly and Company Limited | ||||||||
Full Title: Effect of Duloxetine on Valsalva Leak Point Pressure and Quantitative Rhabdosphincter Electromyography Measures in Women with Stress Urinary Incontinence | ||||||||
Medical condition: stress urinary incontinence | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||
Trial protocol: GB (Completed) DK (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-005074-24 | Sponsor Protocol Number: Feb-02 | Start Date: 2005-02-23 | |||||||||||
Sponsor Name: Febena Pharma GmbH | |||||||||||||
Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF AN OINTMENT FORMULATION CONTAINING DEXAMETHASONE IN PATIENTS WITH RHINOSINUSITIS A CLINICAL PHASE IV ... | |||||||||||||
Medical condition: Patients with allergy-induced, non-infectious diseases of the nasal mucosa (e. g. hay fever) and the sinuses. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002020-17 | Sponsor Protocol Number: 10908458 | Start Date: 2005-02-23 | ||||||
Sponsor Name: Catalan Society of Family Medicine, represented by Dr Mariano de la Figuera Von Wichman and Gabriel | ||||||||
Full Title: ESTRATEGIAS PARA EL TRATAMIENTO DE LA HIPERTENSIÓN ARTERIAL. EVALUACIÓN DE UNA TERAPIA COMBINADA A DOSIS FIJAS (LOSARTÁN/HIDROCLOROTIAZIDA) vs MONOTERAPIA (ESTRATAAR). (STRATEGIES FOR THE TREATMENT... | ||||||||
Medical condition: Stage II arterial Hypertension | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: ES (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004899-36 | Sponsor Protocol Number: Mekos 05 P379/1 | Start Date: 2005-02-23 | ||||||
Sponsor Name: Mekos Laboratories | ||||||||
Full Title: Clinical evaluation of the 3 allergens: Methyldibromoglutharonitrile, Parthenolide and Goldsodiumthiosulphate for "TRUE Test Panel 3" - a phase II, dose-response study. | ||||||||
Medical condition: Diagnosis of Allergic Contact Dermatitis. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: SE (Ongoing) DK (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000903-17 | Sponsor Protocol Number: CN138-166 | Start Date: 2005-02-23 | ||||||
Sponsor Name: Bristol-Myers Squibb International Corporation | ||||||||
Full Title: A Prospective, Multicenter, Open-Label Study to Evaluate the Effectiveness and the Effect on Cognitive Functioning of a Treatment with Aripiprazole in a Broad Range of Schizophrenic Patients | ||||||||
Medical condition: Schizophrenia | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: BE (Completed) | ||||||||
Trial results: View results |